But it does have CE Mark and TGA. And a bunch of distributors lined up waiting for stock to sell into their jurisdictions.
Look this journey has taken a while so some here may have forgotten the margins we were talking about on sales. I've attached the most reliable summary post i could find that referenced the relevant investor presentation here 21079943
With robust clinical trials showing the efficacy of the Mente device, and clearances in these countries, its now up to the distributors to market the device. Given the well entrenched Autism support communities already exist, i would think this would be a relatively simple strategy to quickly boost recognition and demand.
With the type of margins we are referencing above of well over $1000AUD per device, it seems to me that an entry at 16c is a gift.
- Forums
- ASX - By Stock
- NTI
- Ann: US Clinical Trial Results Published
Ann: US Clinical Trial Results Published, page-38
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.001(1.45%) |
Mkt cap ! $64.55M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 7.0¢ | $16.67K | 237.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 75250 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 23082 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 589299 | 0.070 |
1 | 36231 | 0.069 |
5 | 240000 | 0.068 |
2 | 255000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.076 | 90000 | 1 |
0.077 | 190000 | 3 |
Last trade - 14.13pm 28/11/2024 (20 minute delay) ? |
NTI (ASX) Chart |